Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Surgery Partners (SGRY) Depreciation & Amortization (IS) (2016 - 2025)

Surgery Partners (SGRY) has disclosed Depreciation & Amortization (IS) for 12 consecutive years, with $59.9 million as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (IS) rose 76.7% to $59.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $176.0 million through Dec 2025, up 15.33% year-over-year, with the annual reading at $176.0 million for FY2025, 15.33% up from the prior year.
  • Depreciation & Amortization (IS) hit $59.9 million in Q4 2025 for Surgery Partners, up from $39.5 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (IS) ranged from a high of $59.9 million in Q4 2025 to a low of $22.7 million in Q4 2021.
  • Historically, Depreciation & Amortization (IS) has averaged $33.0 million across 5 years, with a median of $30.4 million in 2022.
  • Biggest YoY gain for Depreciation & Amortization (IS) was 76.7% in 2025; the steepest drop was 21.31% in 2025.
  • Year by year, Depreciation & Amortization (IS) stood at $22.7 million in 2021, then skyrocketed by 30.4% to $29.6 million in 2022, then increased by 5.07% to $31.1 million in 2023, then grew by 9.0% to $33.9 million in 2024, then surged by 76.7% to $59.9 million in 2025.
  • Business Quant data shows Depreciation & Amortization (IS) for SGRY at $59.9 million in Q4 2025, $39.5 million in Q3 2025, and $40.3 million in Q2 2025.